Advertisement
UK markets close in 2 hours 5 minutes

  • FTSE 100

    8,073.64
    +28.83 (+0.36%)
     

  • FTSE 250

    19,765.36
    -34.36 (-0.17%)
     

  • AIM

    755.14
    +0.27 (+0.04%)
     

  • GBP/EUR

    1.1642
    +0.0014 (+0.12%)
     

  • GBP/USD

    1.2451
    -0.0002 (-0.01%)
     

  • Bitcoin GBP

    53,069.46
    -30.96 (-0.06%)
     

  • CMC Crypto 200

    1,429.84
    +5.74 (+0.40%)
     

  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     

  • DOW

    38,503.69
    +263.71 (+0.69%)
     

  • CRUDE OIL

    82.89
    -0.47 (-0.56%)
     

  • GOLD FUTURES

    2,336.10
    -6.00 (-0.26%)
     

  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

  • HANG SENG

    17,201.27
    +372.34 (+2.21%)
     

  • DAX

    18,145.60
    +7.95 (+0.04%)
     

  • CAC 40

    8,130.81
    +25.03 (+0.31%)
     
Money:

The five essential pieces of financial paperwork you must never lose

Mislaying key documents can cause real headaches, so it’s worth tracking down these most commonly-lost bits of paperwork

British healthcare firm BTG settles DoJ probe into U.S. unit

Reuters

Oct 6 (Reuters) - British healthcare group BTG Plc said it agreed to settle an investigation into one of its U.S. units, Biocompatibles, with the U.S. Department of Justice for $36 million.

BTG said its 2016-17 forecast for selling, general and administrative expenses did not include the effect of the settlement.

Earlier on Thursday, the company said it saw full-year revenue ahead of its previous forecast.

BTG agreed to settle all allegations regarding the investigation, which focused on the period before it acquired the oncology products supplier Biocompatibles in 2011.

($1 = 0.79 pounds)

(Reporting by Mamidipudi Soumithri in Bengaluru; Editing by Martina D'Couto)